Efficacy and breadth of adjuvanted SARS-CoV-2 receptor-binding domain nanoparticle vaccine in macaques
Hannah A. D. King(Henry M. Jackson Foundation), Diane L. Bolton(Henry M. Jackson Foundation)
Cited by 66
Related Papers
14-3-3 theta binding to cell cycle regulatory factors is enhanced by HIV-1 Vpr
|Biology Direct|2008|22
Efficacy and breadth of adjuvanted SARS-CoV-2 receptor-binding domain nanoparticle vaccine in macaques
|bioRxiv (Cold Spring Harbor Laboratory)|2021|13
Limitations and use of the Morpheus-V5 dual reporter virus in assessing interventions that target HIV latency
|Journal of Virological Methods|2025|1